SEC Form 4 research
| Issuer | Verrica Pharmaceuticals Inc. |
|---|---|
| Tickers | VRCA |
| Reporting owners | 29 |
| Officers and directors | 15 |
| Last public filing | 2026-08-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-18 | 2026-08-17 | Zawitz David | P | 6,000 | $4.98 | Not reported |
| 2026-08-18 | 2026-08-17 | Rieger Jayson | P | 5,000 | $4.91 | Not reported |
| 2026-08-18 | 2026-08-14 | Rieger Jayson | P | 20,000 | $5.06 | Not reported |
| 2026-08-18 | 2026-08-18 | Rosenberg Noah L. | P | 2,030 | $4.92 | Not reported |
| 2026-08-18 | 2026-08-17 | Rosenberg Noah L. | P | 4,200 | $4.91 | Not reported |
| 2026-08-18 | 2026-08-18 | Kirby John J. | P | 5,000 | $4.93 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.